Cargando…
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease
Patients with SCAD and concomitant COPD are at high risk of cardiovascular adverse events, due to chronic inflammation, responsible of endothelial dysfunction, oxidative stress and heightened platelet reactivity (PR). The objective of this randomised clinical trial was to test if ticagrelor is super...
Autores principales: | Campo, Gianluca, Dalla Sega, Francesco Vieceli, Pavasini, Rita, Aquila, Giorgio, Gallo, Francesco, Fortini, Francesca, Tonet, Elisabetta, Cimaglia, Paolo, Del Franco, Annamaria, Pestelli, Gabriele, Pecoraro, Alessandro, Contoli, Marco, Balla, Cristina, Biscaglia, Simone, Rizzo, Paola, Ferrari, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Schattauer GmbH
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291849/ https://www.ncbi.nlm.nih.gov/pubmed/28331925 http://dx.doi.org/10.1160/TH16-12-0973 |
Ejemplares similares
-
Ticagrelor Improves Endothelial Function by Decreasing Circulating Epidermal Growth Factor (EGF)
por: Vieceli Dalla Sega, Francesco, et al.
Publicado: (2018) -
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial
por: Biscaglia, Simone, et al.
Publicado: (2017) -
COX-2 Is Downregulated in Human Stenotic Aortic Valves and Its Inhibition Promotes Dystrophic Calcification
por: Vieceli Dalla Sega, Francesco, et al.
Publicado: (2020) -
Ticagrelor Increases SIRT1 and HES1 mRNA Levels in Peripheral Blood Cells from Patients with Stable Coronary Artery Disease and Chronic Obstructive Pulmonary Disease
por: Aquila, Giorgio, et al.
Publicado: (2020) -
Notch Signaling Regulates Immune Responses in Atherosclerosis
por: Vieceli Dalla Sega, Francesco, et al.
Publicado: (2019)